A nonhuman primate toxicology and immunogenicity study evaluating aerosol delivery of AERAS-402/Ad35 vaccine

References

• Andersen P, Doherty TM. The success and failure of BCG - implications for a novel tuberculosis vaccine. Nat Rev Microbiol 2005; 3:656 - 62; http://dx.doi.org/10.1038/nrmicro1211; PMID: 16012514
   PubMed Web of Science ®Google Scholar
• Barker LF, Brennan MJ, Rosenstein PK, Sadoff JC. Tuberculosis vaccine research: the impact of immunology. Curr Opin Immunol 2009; 21:331 - 8; http://dx.doi.org/10.1016/j.coi.2009.05.017; PMID: 19505813
   PubMed Web of Science ®Google Scholar
• Rodrigues LC, Diwan VK, Wheeler JG. Protective effect of BCG against tuberculous meningitis and miliary tuberculosis: a meta-analysis. Int J Epidemiol 1993; 22:1154 - 8; http://dx.doi.org/10.1093/ije/22.6.1154; PMID: 8144299
   PubMed Web of Science ®Google Scholar
• Trunz BB, Fine P, Dye C. Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a meta-analysis and assessment of cost-effectiveness. Lancet 2006; 367:1173 - 80; http://dx.doi.org/10.1016/S0140-6736(06)68507-3; PMID: 16616560
   PubMed Web of Science ®Google Scholar
• Mangtani P, Abubakar I, Ariti C, Beynon R, Pimpin L, Fine PE, Rodrigues LC, Smith PG, Lipman M, Whiting PF, et al. Protection by BCG vaccine against tuberculosis: a systematic review of randomized controlled trials. Clin Infect Dis 2014; 58:470 - 80; http://dx.doi.org/10.1093/cid/cit790; PMID: 24336911
   PubMed Web of Science ®Google Scholar
• Global Tuberculosis Report 2012. Geneva, Switzerland: World Health Organization, 2012.
   Google Scholar
• Cohn DL, Bustreo F, Raviglione MC, International Union Against Tuberculosis and Lung Disease. Drug-resistant tuberculosis: review of the worldwide situation and the WHO/IUATLD Global Surveillance Project. Clin Infect Dis 1997; 24:Suppl 1 S121 - 30; http://dx.doi.org/10.1093/clinids/24.Supplement_1.S121; PMID: 8994791
   PubMed Web of Science ®Google Scholar
• Falzon D, Jaramillo E, Schünemann HJ, Arentz M, Bauer M, Bayona J, Blanc L, Caminero JA, Daley CL, Duncombe C, et al. WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update. Eur Respir J 2011; 38:516 - 28; http://dx.doi.org/10.1183/09031936.00073611; PMID: 21828024
   PubMed Web of Science ®Google Scholar
• Udwadia ZF, Amale RA, Ajbani KK, Rodrigues C. Totally drug-resistant tuberculosis in India. Clin Infect Dis 2012; 54:579 - 81; http://dx.doi.org/10.1093/cid/cir889; PMID: 22190562
   PubMed Web of Science ®Google Scholar
• Masjedi MR, Tabarsi P, Baghaei P, Jalali S, Farnia P, Chitsaz E, Amiri M, Mansouri D, Velayati AA. Extensively drug-resistant tuberculosis treatment outcome in Iran: a case series of seven patients. Int J Infect Dis 2010; 14:e399 - 402; http://dx.doi.org/10.1016/j.ijid.2009.07.002; PMID: 19818664
   PubMed Web of Science ®Google Scholar
• Velayati AA, Farnia P, Masjedi MR, Ibrahim TA, Tabarsi P, Haroun RZ, Kuan HO, Ghanavi J, Farnia P, Varahram M. Totally drug-resistant tuberculosis strains: evidence of adaptation at the cellular level. Eur Respir J 2009; 34:1202 - 3; http://dx.doi.org/10.1183/09031936.00081909; PMID: 19880622
   PubMed Web of Science ®Google Scholar
• Velayati AA, Masjedi MR, Farnia P, Tabarsi P, Ghanavi J, Ziazarifi AH, Hoffner SE. Emergence of new forms of totally drug-resistant tuberculosis bacilli: super extensively drug-resistant tuberculosis or totally drug-resistant strains in iran. Chest 2009; 136:420 - 5; http://dx.doi.org/10.1378/chest.08-2427; PMID: 19349380
   PubMed Web of Science ®Google Scholar
• Tufariello JM, Chan J, Flynn JL. Latent tuberculosis: mechanisms of host and bacillus that contribute to persistent infection. Lancet Infect Dis 2003; 3:578 - 90; http://dx.doi.org/10.1016/S1473-3099(03)00741-2; PMID: 12954564
   PubMed Web of Science ®Google Scholar
• Chaisson RE, Martinson NA. Tuberculosis in Africa--combating an HIV-driven crisis. N Engl J Med 2008; 358:1089 - 92; http://dx.doi.org/10.1056/NEJMp0800809; PMID: 18337598
   PubMed Web of Science ®Google Scholar
• Pacheco AG, Durovni B, Cavalcante SC, Lauria LM, Moore RD, Moulton LH, Chaisson RE, Golub JE. AIDS-related tuberculosis in Rio de Janeiro, Brazil. PLoS One 2008; 3:e3132; http://dx.doi.org/10.1371/journal.pone.0003132; PMID: 18781195
   PubMedGoogle Scholar
• Feller L, Wood NH, Chikte UM, Khammissa RA, Meyerov R, Lemmer J. Tuberculosis part 3: HIV-tuberculosis co-infection. SADJ 2009; 64:352 - 4; PMID: 20034289
   PubMedGoogle Scholar
• Chen CY, Huang D, Wang RC, Shen L, Zeng G, Yao S, Shen Y, Halliday L, Fortman J, McAllister M, et al. A critical role for CD8 T cells in a nonhuman primate model of tuberculosis. PLoS Pathog 2009; 5:e1000392; http://dx.doi.org/10.1371/journal.ppat.1000392; PMID: 19381260
   PubMed Web of Science ®Google Scholar
• Lin PL, Rodgers M, Smith L, Bigbee M, Myers A, Bigbee C, Chiosea I, Capuano SV, Fuhrman C, Klein E, et al. Quantitative comparison of active and latent tuberculosis in the cynomolgus macaque model. Infect Immun 2009; 77:4631 - 42; http://dx.doi.org/10.1128/IAI.00592-09; PMID: 19620341
   PubMed Web of Science ®Google Scholar
• Iwata M, Hirakiyama A, Eshima Y, Kagechika H, Kato C, Song SY. Retinoic acid imprints gut-homing specificity on T cells. Immunity 2004; 21:527 - 38; http://dx.doi.org/10.1016/j.immuni.2004.08.011; PMID: 15485630
   PubMed Web of Science ®Google Scholar
• Mora JR, Bono MR, Manjunath N, Weninger W, Cavanagh LL, Rosemblatt M, Von Andrian UH. Selective imprinting of gut-homing T cells by Peyer’s patch dendritic cells. Nature 2003; 424:88 - 93; http://dx.doi.org/10.1038/nature01726; PMID: 12840763
   PubMed Web of Science ®Google Scholar
• Picker LJ. Control of lymphocyte homing. Curr Opin Immunol 1994; 6:394 - 406; http://dx.doi.org/10.1016/0952-7915(94)90118-X; PMID: 7917107
   PubMed Web of Science ®Google Scholar
• Stagg AJ, Kamm MA, Knight SC. Intestinal dendritic cells increase T cell expression of alpha4beta7 integrin. Eur J Immunol 2002; 32:1445 - 54; http://dx.doi.org/10.1002/1521-4141(200205)32:5<1445::AID-IMMU1445>3.0.CO;2-E; PMID: 11981833
   PubMed Web of Science ®Google Scholar
• Hokey DA, Misra A. Aerosol vaccines for tuberculosis: a fine line between protection and pathology. Tuberculosis (Edinb) 2011; 91:82 - 5; http://dx.doi.org/10.1016/j.tube.2010.09.007; PMID: 21067975
   PubMed Web of Science ®Google Scholar
• Schwander S, Dheda K. Human lung immunity against Mycobacterium tuberculosis: insights into pathogenesis and protection. Am J Respir Crit Care Med 2011; 183:696 - 707; http://dx.doi.org/10.1164/rccm.201006-0963PP; PMID: 21075901
   PubMed Web of Science ®Google Scholar
• Jin TH, Tsao E, Goudsmit J, Dheenadhayalan V, Sadoff J. Stabilizing formulations for inhalable powders of an adenovirus 35-vectored tuberculosis (TB) vaccine (AERAS-402). Vaccine 2010; 28:4369 - 75; http://dx.doi.org/10.1016/j.vaccine.2010.04.059; PMID: 20444437
   PubMed Web of Science ®Google Scholar
• Lu D, Hickey AJ. Pulmonary vaccine delivery. Expert Rev Vaccines 2007; 6:213 - 26; http://dx.doi.org/10.1586/14760584.6.2.213; PMID: 17408371
   PubMed Web of Science ®Google Scholar
• Sené C, Bout A, Imler JL, Schultz H, Willemot JM, Hennebel V, Zurcher C, Valerio D, Lamy D, Pavirani A. Aerosol-mediated delivery of recombinant adenovirus to the airways of nonhuman primates. Hum Gene Ther 1995; 6:1587 - 93; http://dx.doi.org/10.1089/hum.1995.6.12-1587; PMID: 8664383
   PubMed Web of Science ®Google Scholar
• Hodge LM, Marinaro M, Jones HP, McGhee JR, Kiyono H, Simecka JW, Immunoglobulin A. Immunoglobulin A (IgA) responses and IgE-associated inflammation along the respiratory tract after mucosal but not systemic immunization. Infect Immun 2001; 69:2328 - 38; http://dx.doi.org/10.1128/IAI.69.4.2328-2338.2001; PMID: 11254590
   PubMed Web of Science ®Google Scholar
• Simecka JW, Jackson RJ, Kiyono H, McGhee JR. Mucosally induced immunoglobulin E-associated inflammation in the respiratory tract. Infect Immun 2000; 68:672 - 9; http://dx.doi.org/10.1128/IAI.68.2.672-679.2000; PMID: 10639432
   PubMed Web of Science ®Google Scholar
• Gordon S. Alternative activation of macrophages. Nat Rev Immunol 2003; 3:23 - 35; http://dx.doi.org/10.1038/nri978; PMID: 12511873
   PubMed Web of Science ®Google Scholar
• Radosevic K, Wieland CW, Rodriguez A, Weverling GJ, Mintardjo R, Gillissen G, Vogels R, Skeiky YA, Hone DM, Sadoff JC, et al. Protective immune responses to a recombinant adenovirus type 35 tuberculosis vaccine in two mouse strains: CD4 and CD8 T-cell epitope mapping and role of gamma interferon. Infect Immun 2007; 75:4105 - 15; http://dx.doi.org/10.1128/IAI.00004-07; PMID: 17526747
   PubMed Web of Science ®Google Scholar
• Ronan EO, Lee LN, Tchilian EZ, Beverley PC. Nasal associated lymphoid tissue (NALT) contributes little to protection against aerosol challenge with Mycobacterium tuberculosis after immunisation with a recombinant adenoviral vaccine. Vaccine 2010; 28:5179 - 84; http://dx.doi.org/10.1016/j.vaccine.2010.05.075; PMID: 20558252
   PubMed Web of Science ®Google Scholar
• Wang J, Thorson L, Stokes RW, Santosuosso M, Huygen K, Zganiacz A, Hitt M, Xing Z. Single mucosal, but not parenteral, immunization with recombinant adenoviral-based vaccine provides potent protection from pulmonary tuberculosis. J Immunol 2004; 173:6357 - 65; http://dx.doi.org/10.4049/jimmunol.173.10.6357; PMID: 15528375
   PubMed Web of Science ®Google Scholar
• Xing Z, McFarland CT, Sallenave JM, Izzo A, Wang J, McMurray DN. Intranasal mucosal boosting with an adenovirus-vectored vaccine markedly enhances the protection of BCG-primed guinea pigs against pulmonary tuberculosis. PLoS One 2009; 4:e5856; http://dx.doi.org/10.1371/journal.pone.0005856; PMID: 19516906
   PubMed Web of Science ®Google Scholar
• Minne A, Louahed J, Mehauden S, Baras B, Renauld JC, Vanbever R. The delivery site of a monovalent influenza vaccine within the respiratory tract impacts on the immune response. Immunology 2007; 122:316 - 25; http://dx.doi.org/10.1111/j.1365-2567.2007.02641.x; PMID: 17521369
   PubMed Web of Science ®Google Scholar
• Abel B, Tameris M, Mansoor N, Gelderbloem S, Hughes J, Abrahams D, Makhethe L, Erasmus M, de Kock M, van der Merwe L, et al. The novel tuberculosis vaccine, AERAS-402, induces robust and polyfunctional CD4+ and CD8+ T cells in adults. Am J Respir Crit Care Med 2010; 181:1407 - 17; http://dx.doi.org/10.1164/rccm.200910-1484OC; PMID: 20167847
   PubMed Web of Science ®Google Scholar
• Hoft DF, Blazevic A, Stanley J, Landry B, Sizemore D, Kpamegan E, Gearhart J, Scott A, Kik S, Pau MG, et al. A recombinant adenovirus expressing immunodominant TB antigens can significantly enhance BCG-induced human immunity. Vaccine 2012; 30:2098 - 108; http://dx.doi.org/10.1016/j.vaccine.2012.01.048; PMID: 22296955
   PubMed Web of Science ®Google Scholar
• Song K, Bolton DL, Wei CJ, Wilson RL, Camp JV, Bao S, Mattapallil JJ, Herzenberg LA, Herzenberg LA, Andrews CA, et al. Genetic immunization in the lung induces potent local and systemic immune responses. Proc Natl Acad Sci U S A 2010; 107:22213 - 8; http://dx.doi.org/10.1073/pnas.1015536108; PMID: 21135247
   PubMed Web of Science ®Google Scholar
• Streilein JW. Ocular immune privilege: the eye takes a dim but practical view of immunity and inflammation. J Leukoc Biol 2003; 74:179 - 85; http://dx.doi.org/10.1189/jlb.1102574; PMID: 12885934
   PubMed Web of Science ®Google Scholar
• Zuckerman JB, Robinson CB, McCoy KS, Shell R, Sferra TJ, Chirmule N, Magosin SA, Propert KJ, Brown-Parr EC, Hughes JV, et al. A phase I study of adenovirus-mediated transfer of the human cystic fibrosis transmembrane conductance regulator gene to a lung segment of individuals with cystic fibrosis. Hum Gene Ther 1999; 10:2973 - 85; http://dx.doi.org/10.1089/10430349950016384; PMID: 10609658
   PubMed Web of Science ®Google Scholar
• McDonald RJ, Lukason MJ, Raabe OG, Canfield DR, Burr EA, Kaplan JM, Wadsworth SC, St George JA. Safety of airway gene transfer with Ad2/CFTR2: aerosol administration in the nonhuman primate. Hum Gene Ther 1997; 8:411 - 22; http://dx.doi.org/10.1089/hum.1997.8.4-411; PMID: 9054516
   PubMed Web of Science ®Google Scholar
• Lerondel S, Vecellio None L, Faure L, Sizaret PY, Sene C, Pavirani A, Diot P, Le Pape A. Gene therapy for cystic fibrosis with aerosolized adenovirus-CFTR: characterization of the aerosol and scintigraphic determination of lung deposition in baboons. J Aerosol Med 2001; 14:95 - 105; http://dx.doi.org/10.1089/08942680152007945; PMID: 11495490
   PubMedGoogle Scholar
• Meyer KC, Sharma A. Regional variability of lung inflammation in cystic fibrosis. Am J Respir Crit Care Med 1997; 156:1536 - 40; http://dx.doi.org/10.1164/ajrccm.156.5.9701098; PMID: 9372672
   PubMed Web of Science ®Google Scholar
• Garcia-Contreras L, Hickey AJ. Aerosol treatment of cystic fibrosis. Crit Rev Ther Drug Carrier Syst 2003; 20:317 - 56; http://dx.doi.org/10.1615/CritRevTherDrugCarrierSyst.v20.i5.10; PMID: 14959788
   PubMed Web of Science ®Google Scholar
• Mikhak Z, Strassner JP, Luster AD. Lung dendritic cells imprint T cell lung homing and promote lung immunity through the chemokine receptor CCR4. J Exp Med 2013; 210:1855 - 69; http://dx.doi.org/10.1084/jem.20130091; PMID: 23960189
   PubMed Web of Science ®Google Scholar
• Turner DL, Bickham KL, Farber DL, Lefrançois L. Splenic priming of virus-specific CD8 T cells following influenza virus infection. J Virol 2013; 87:4496 - 506; http://dx.doi.org/10.1128/JVI.03413-12; PMID: 23388712
   PubMed Web of Science ®Google Scholar
• Waldmann TA. The biology of interleukin-2 and interleukin-15: implications for cancer therapy and vaccine design. Nat Rev Immunol 2006; 6:595 - 601; http://dx.doi.org/10.1038/nri1901; PMID: 16868550
   PubMed Web of Science ®Google Scholar
• Dharmadhikari AS, Basaraba RJ, Van Der Walt ML, Weyer K, Mphahlele M, Venter K, Jensen PA, First MW, Parsons S, McMurray DN, et al. Natural infection of guinea pigs exposed to patients with highly drug-resistant tuberculosis. Tuberculosis (Edinb) 2011; 91:329 - 38; http://dx.doi.org/10.1016/j.tube.2011.03.002; PMID: 21478054
   PubMed Web of Science ®Google Scholar
• Mills CC, O’Grady F, Riley RL. Tuberculin conversion in the “naturally infected” guinea pig. Bull Johns Hopkins Hosp 1960; 106:36 - 45; PMID: 14422642
   PubMedGoogle Scholar
• Swift D, Asgharian B, Kimbell J. Use of mathematical aerosol deposition models in predicting the distribution of inhaled therapeutic aerosols. In: Hickey A, ed. Inhaled Aerosols: Physical and Biological Basis for Therapy. New York, NY: Marcel Dekker, Inc., 2006.
   Google Scholar
• Barouch DH, Kik SV, Weverling GJ, Dilan R, King SL, Maxfield LF, Clark S, Ng’ang’a D, Brandariz KL, Abbink P, et al. International seroepidemiology of adenovirus serotypes 5, 26, 35, and 48 in pediatric and adult populations. Vaccine 2011; 29:5203 - 9; http://dx.doi.org/10.1016/j.vaccine.2011.05.025; PMID: 21619905
   PubMed Web of Science ®Google Scholar
• Sprangers MC, Lakhai W, Koudstaal W, Verhoeven M, Koel BF, Vogels R, Goudsmit J, Havenga MJ, Kostense S. Quantifying adenovirus-neutralizing antibodies by luciferase transgene detection: addressing preexisting immunity to vaccine and gene therapy vectors. J Clin Microbiol 2003; 41:5046 - 52; http://dx.doi.org/10.1128/JCM.41.11.5046-5052.2003; PMID: 14605137
   PubMed Web of Science ®Google Scholar